Product Specification
Strength
5 mg
Packaging Type
Injection
Brand
Tirzepatide
Shelf Life
36 months
Usage / Application
used to treat type 2 diabetes
 
Product Description
Tirzepatide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. Tirzapatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist.
 
Name: Tirzepatide
CAS No.: 2023788-19-2
Molecular Formula: C225H348N48O68
Molecular Weight: 4813.527
Appearance: White Lyophilized powder
Package: White Labelling vials. Labels can be customized.
 
Tirzepatide
Tirzepatide is a treatment of type 2 diabetes mellitus. It is an investigational dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, which means that it stimulates the release of insulin in response to glucose levels in the blood, thereby lowering blood sugar levels. Tirzepatide has shown promising results in clinical trials for its efficacy and safety in controlling blood glucose levels, reducing body weight, and improving cardiovascular outcomes.